| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/17/2006 | CA2573130A1 Isolated fungal promoters and gene transcription terminators and methods of protein and chemical production in a fungus |
| 02/16/2006 | WO2006017775A1 Inducible expression systems for modulating the expression of target genes in eukaryotic cells and non-human animals |
| 02/16/2006 | WO2006017577A2 Nucleic acids encoding anthelmintic agents and plants made therefrom |
| 02/16/2006 | WO2006017447A1 Methods of inhibiting vegf-c |
| 02/16/2006 | WO2006017371A1 Methods of producing mutant polynucleotides |
| 02/16/2006 | WO2006017325A2 Aav vector compositions and methods for enhanced expression of immunoglobulins the same |
| 02/16/2006 | WO2006016808A2 Means and methods for producing a stabilized cell of interest |
| 02/16/2006 | WO2006016692A1 Knockout nonhuman animal |
| 02/16/2006 | WO2006016596A1 Production of fibrous ingredient from lignocellulosic material and use of the same |
| 02/16/2006 | WO2006016574A1 ANTINEOPLASTIC AGENT APPLYING RNAi |
| 02/16/2006 | WO2006016275A2 Gastrin-specific interfering rna |
| 02/16/2006 | WO2006016097A2 Vector comprising polymer modified sirna liposomes |
| 02/16/2006 | WO2006015996A1 Animal model of neurodegenerative diseases, method of obtaining same and uses thereof |
| 02/16/2006 | WO2006015976A1 Diagnostic and therapeutic use of a plasma membrane atpase |
| 02/16/2006 | WO2006015887A2 Modulation of alkaloid biosynthesis in plants and plants having altered alkaloid biosynthesis |
| 02/16/2006 | WO2006015789A2 Method for modulating gene expression by modifying the cpg content |
| 02/16/2006 | WO2006015669A1 Method for the production of l-amino acids using strains from the enterobacteraceae family |
| 02/16/2006 | WO2006015557A1 Recombinant live fowlpox virus vectors and their use in pharmaceutical compositions against hepatitis c virus |
| 02/16/2006 | WO2006015426A1 Compositions and methods for angiogenesis-related molecules and treatments |
| 02/16/2006 | WO2006001810A3 Improved inhibitor nucleic acids |
| 02/16/2006 | WO2005123926B1 Method for modifying plant morphology, biochemistry and physiology comprising expression of cytokinin oxydase in the seeds |
| 02/16/2006 | WO2005121366A8 Gene marker and utilization of the same |
| 02/16/2006 | WO2005118794A3 Improved 2-deoxy-d-ribose 5-phosphate aldolases (deras) and the uses thereof |
| 02/16/2006 | WO2005116271A3 Selection of microorganisms with growth dependent upon extracytoplasmic enzymes |
| 02/16/2006 | WO2005115433A3 Methods for cyclizing synthetic polymers |
| 02/16/2006 | WO2005113760A3 Thermostable y-family polymerases and chimeras |
| 02/16/2006 | WO2005103299A3 Rnai-based target identification and validation |
| 02/16/2006 | WO2005103261B1 Modified expandase enzyme and its use |
| 02/16/2006 | WO2005103082A3 Group 1 mite polypeptide variants |
| 02/16/2006 | WO2005098005A3 Systemic gene silencing in plants |
| 02/16/2006 | WO2005095624A3 Filamentous fungal mutants with improved homologous recombination efficiency |
| 02/16/2006 | WO2005080432A3 Cdr-repaired antibodies |
| 02/16/2006 | WO2005077095A3 Ccn1 transgenic animals |
| 02/16/2006 | WO2005073405A3 Catalytic polynucleotide and its use for determination of analytes |
| 02/16/2006 | WO2005067506A3 Method for monitoring and generating high capacity gutless adenoviral vector |
| 02/16/2006 | WO2005049805A3 Fructose-bisphosphate aldolase regulatory sequences for gene expression in oleaginous yeast |
| 02/16/2006 | WO2005048957A3 Novel insertion sites in pox vectors |
| 02/16/2006 | WO2005047509A8 The mycolactone locus : an assembly line for producing novel polyketides, with therapeutic and prophylatic uses |
| 02/16/2006 | WO2005047486A3 Biological production of tetradehydrolycopene |
| 02/16/2006 | WO2005038004A3 Method to product para-hydroxybenzoic acid in the stem tissue of green plants by using a tissue-specific promter |
| 02/16/2006 | WO2005037191A3 Expression of dominant negative transmembrane receptors in the milk of transgenic animals |
| 02/16/2006 | WO2005032455A8 Combinatorially selected phosphorodithioate aptamer targeting ap-1 |
| 02/16/2006 | WO2005021557A3 Poly-pegylated protease inhibitors |
| 02/16/2006 | WO2005020916A3 Myoblast treatment of diseased or weakened organs |
| 02/16/2006 | WO2005014791A3 Methods and compositions for targeted cleavage and recombination |
| 02/16/2006 | WO2004089285A3 Phosphodiesterase 2a and methods of use |
| 02/16/2006 | WO2004078946A3 Rnai arrays and methods for using the same |
| 02/16/2006 | WO2004078936A3 Methods for preventing gluconoylation of proteins |
| 02/16/2006 | WO2004071430A3 RNAi TARGETING OF VIRUSES |
| 02/16/2006 | WO2004062365A3 Stem-regulated, plant defense promoter and uses thereof in tissue-specific expression in monocots |
| 02/16/2006 | WO2004048515A3 Streptococcus uberis adhesion molecule |
| 02/16/2006 | WO2004047720A3 Methods of inhibiting angiogensis via modification of a lysyl oxidase |
| 02/16/2006 | WO2004043391A3 Modulation of mitogen-activated protein kinase kinase kinase 11 expression |
| 02/16/2006 | WO2003091402A3 N-ACETYLGLUCOSAMINYLTRANSFERASE Vb CODING SEQUENCE, RECOMBINANT CELLS AND METHODS |
| 02/16/2006 | WO2003089604A3 Methods of creating modified promoters resulting in varying levels of gene expression |
| 02/16/2006 | WO2003083058A3 Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 02/16/2006 | WO2003033720A8 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 02/16/2006 | WO2003025129A3 Neurotransmission-associated proteins |
| 02/16/2006 | US20060037111 Cotton cultivar DP 6222 RR acala |
| 02/16/2006 | US20060037109 Alteration of amino acid compositions in seeds |
| 02/16/2006 | US20060037108 Stress tolerance and delayed senescence in plants |
| 02/16/2006 | US20060037107 Production of antibodies |
| 02/16/2006 | US20060037106 Method for modifying plant growth characteristics |
| 02/16/2006 | US20060037105 Agroinoculation method for virus induced gene silencing |
| 02/16/2006 | US20060037104 Transgenic seeds to produce oils having improved oxidative stability and melting characteristics, and no need for hydrogenation; improved nutritional characteristics by modified fatty acids; fatty acid biosynthesis gene selected from desaturases/ gene silencing |
| 02/16/2006 | US20060037103 Expression vector comprising cytokinin regulatory sequences for use as tool in enhancement of fatty acid and carbohydrate metabolism in plants; spatial and temporal specificity in heterologous gene transcription |
| 02/16/2006 | US20060037102 Sugar and lipid metabolism regulators in plants IV |
| 02/16/2006 | US20060037101 Inhibitory nucleotide sequences specific for nematode chaperonin gene for use in treatment and prevention of parasitic infection of plants; disease resistant plants; biological pest control |
| 02/16/2006 | US20060037100 Fungal resistant transgenic pepper plants and their production method |
| 02/16/2006 | US20060037099 Method of controlling gene expression in plants or plant cells |
| 02/16/2006 | US20060037097 Plant disease resistance genes |
| 02/16/2006 | US20060037096 Cloning of cytochrome p450 genes from nicotiana |
| 02/16/2006 | US20060037095 Corn event TC1507 and methods for detection thereof |
| 02/16/2006 | US20060037094 Secreted protein associated with depression, compositions and methods of use thereof |
| 02/16/2006 | US20060037093 Transgenic transchromosomal rodents for making human antibodies |
| 02/16/2006 | US20060037092 Universal stem cells |
| 02/16/2006 | US20060037086 Methods for correcting mitotic spindle defects and optimizing preimplantation embryonic developmental rates associated with somatic cell nuclear transfer in animals |
| 02/16/2006 | US20060036089 33 human secreted proteins |
| 02/16/2006 | US20060036088 Natural promoters for gene expression in C1 metabolizing bacteria |
| 02/16/2006 | US20060036078 Fluorescent proteins |
| 02/16/2006 | US20060036074 Bromodomain protein |
| 02/16/2006 | US20060036028 Solid phase synthesis using a solid support prepared by polymerization of a polyarylmethyl-protected alkoxylated styrene monomer that has 2-10 oxyalkylene units |
| 02/16/2006 | US20060035858 Methods for modulating lipoprotein and cholesterol levels in humans |
| 02/16/2006 | US20060035857 Methods and compositions for the diagnosis and treatment of cancer |
| 02/16/2006 | US20060035856 Purified polypeptides having IL-13 receptor activity |
| 02/16/2006 | US20060035855 Purified polypeptides having IL-13 receptor activity |
| 02/16/2006 | US20060035849 Methods and composition for modulating type I muscle formation using pgc-1 alpha |
| 02/16/2006 | US20060035818 Use of corticotroph-derived glycoprotein hormone to induce lipolysis |
| 02/16/2006 | US20060035815 Pharmaceutical compositions for delivery of ribonucleic acid to a cell |
| 02/16/2006 | US20060035814 Reagents and methods for smooth muscle therapies |
| 02/16/2006 | US20060035786 use of a polypeptide with the biological activity of sucrose-6-phosphate phosphatase which, if not present, brings about growth retardation symptoms and chlorotic leaves; method for identifying herbicidal or growth-regulatory compounds which inhibit the enzyme; herbicides or growth regulators |
| 02/16/2006 | US20060035379 Genes encoding wheat starch synthases and uses thereof |
| 02/16/2006 | US20060035378 Modified viral vector particles |
| 02/16/2006 | US20060035377 Pathogen-resistant grape plants |
| 02/16/2006 | US20060035373 Stem cell libraries |
| 02/16/2006 | US20060035371 Hybrid adeno-retroviral vector for the transfection of cells |
| 02/16/2006 | US20060035367 Proteases from gram positive organisms |
| 02/16/2006 | US20060035366 Transglutaminase-producing strain |
| 02/16/2006 | US20060035365 Method for identifying cellular growth inhibitors |
| 02/16/2006 | US20060035363 Novel acylase gene |